{"id":2461,"date":"2023-01-04T00:04:01","date_gmt":"2023-01-04T00:04:01","guid":{"rendered":"https:\/\/www.fziomed.com\/usa\/?p=2461"},"modified":"2023-01-04T00:04:01","modified_gmt":"2023-01-04T00:04:01","slug":"fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo","status":"publish","type":"post","link":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/","title":{"rendered":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO"},"content":{"rendered":"<p><em>New CEO Paul Mraz also joins FzioMed Inc.\u2019s Board of Directors; <\/em><\/p>\n<p><em>Company set to accelerate growth of market leading Oxiplex\u00ae adhesion barrier products.<\/em><\/p>\n<p><strong>SAN LUIS OBISPO, California, January 3, 2023 \u2014 FzioMed, Inc.<\/strong> (\u201cFzioMed\u201d or the \u201cCompany\u201d), a global leading surgical biomaterials company focused on spine\/orthopedic, peritoneal and gynecological surgery, today announced the appointment of industry veteran Paul Mraz as its new President and CEO and member of the Board of Directors. Mraz\u2019s appointment became effective Jan. 1, 2023, commensurate with the retirement of John Krelle who served in the leadership role since 2005.<\/p>\n<p>\u201cOn behalf of the Board of Directors, I want to thank John for his many years of service to FzioMed, his outstanding leadership, commitment to our values and dedication to the Company, its employees, customers and stakeholders. John led FzioMed through a period of growth and transformation and we wish him the very best in his retirement,\u201d said Ron Haynes, Executive Chairman of the Board.<\/p>\n<p>\u201cWe are very pleased to name Paul Mraz as President and CEO of FzioMed. Paul is a seasoned leader with a successful track record of execution and shareholder value creation across numerous medical device businesses worldwide. He brings an incredible amount of energy and strategic skills to the company as well as a deep understanding of global surgical markets,\u201d continued Haynes.<\/p>\n<p>Mraz joins the company with broad industry experience having served as President and CEO at multiple medical device and biomaterials companies. From innovative startups to the world\u2019s largest healthcare companies, Mraz has been responsible for the success of numerous game changing medical technologies during his 30+ year career in the life sciences industry. Most recently, Mraz was president and CEO of ApiFix Ltd., acquired by OrthoPediatrics Corp. (Nasdaq: KIDS) in 2020, where he continued to serve as SVP and General Manager of its Scoliosis franchise.<\/p>\n<p>\u201cThe FzioMed team has built a strong organization with a bright future, and I am honored to lead the next phase of the Company\u2019s growth,\u201d said Paul Mraz. \u201cOur flagship family of Oxiplex\u00ae products have 20 years of clinical use with more than 750,000 units utilized in 72 countries around the globe. I am excited to join FzioMed at a time when we look to broaden the adoption of our Oxiplex\u00ae technology across orthopedics, spine and women\u2019s health including our first commercial introduction in the United States.\u201d<\/p>\n<p>FzioMed is well positioned with substantial technology assets, a talented workforce and a pipeline of novel proprietary products as a global leader in the surgical biomaterials markets for adhesion prevention.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About FzioMed, Inc.<\/strong><\/p>\n<p>Founded in 1996, FzioMed is a privately held medical device and biomaterials company focused exclusively on preserving surgical excellence in spine\/orthopedic, peritoneal and gynecological surgery.<\/p>\n<p>The Company develops, manufactures absorbable adhesion barriers based on its patented polymer technology and currently markets and distributes its products in 72 countries outside the United States under various brand names including Oxiplex\u00ae, Oxiplex\/SP\u00ae, Oxiplex\/AP\u00ae, Oxiplex\/IU\u00ae, Dynavisc\u00ae, MediShield and Interpose\u00ae.<\/p>\n<p>Oxiplex\u00ae is an absorbable gel applied to tissues and organs following surgery and related procedures.\u00a0In spine surgery, Oxiplex\u00ae creates a temporary physical barrier between adjacent tissues and has been shown in multiple peer reviewed studies to reduce leg pain, back pain and neurologic symptoms.<\/p>\n<p>FzioMed\u00ae, Oxiplex\u00ae, Oxiplex\/SP\u00ae, Oxiplex\/AP\u00ae, Oxiplex\/IU\u00ae, Dynavisc\u00ae, and Interpose\u00ae are registered trademarks of FzioMed, Inc.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.fziomed.com\/usa\">www.fziomed.com\/usa<\/a>\u00a0or contact\u00a0<a href=\"mailto:investorrelations@fziomed.com\">investorrelations@fziomed.com<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>New CEO Paul Mraz also joins FzioMed Inc.\u2019s Board of Directors; Company set to accelerate growth of market leading Oxiplex\u00ae adhesion barrier products. SAN LUIS OBISPO, California, January 3, 2023 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a global leading surgical biomaterials company focused on spine\/orthopedic, peritoneal and gynecological surgery, today announced the appointment of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[44],"tags":[],"class_list":["post-2461","post","type-post","status-publish","format-standard","hentry","category-news-releases","pmpro-has-access"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA\" \/>\n<meta property=\"og:description\" content=\"New CEO Paul Mraz also joins FzioMed Inc.\u2019s Board of Directors; Company set to accelerate growth of market leading Oxiplex\u00ae adhesion barrier products. SAN LUIS OBISPO, California, January 3, 2023 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a global leading surgical biomaterials company focused on spine\/orthopedic, peritoneal and gynecological surgery, today announced the appointment of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Fziomed USA\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-04T00:04:01+00:00\" \/>\n<meta name=\"author\" content=\"raincastle\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"raincastle\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/\"},\"author\":{\"name\":\"raincastle\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\"},\"headline\":\"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO\",\"datePublished\":\"2023-01-04T00:04:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/\"},\"wordCount\":576,\"commentCount\":0,\"articleSection\":[\"News Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/\",\"name\":\"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\"},\"datePublished\":\"2023-01-04T00:04:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#website\",\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/\",\"name\":\"Fziomed USA\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/#\\\/schema\\\/person\\\/d08a21ddbf0edf65250f5c26f5e2f05c\",\"name\":\"raincastle\",\"sameAs\":[\"https:\\\/\\\/www.fziomed.com\"],\"url\":\"https:\\\/\\\/www.fziomed.com\\\/usa\\\/author\\\/raincastle\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/","og_locale":"en_US","og_type":"article","og_title":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA","og_description":"New CEO Paul Mraz also joins FzioMed Inc.\u2019s Board of Directors; Company set to accelerate growth of market leading Oxiplex\u00ae adhesion barrier products. SAN LUIS OBISPO, California, January 3, 2023 \u2014 FzioMed, Inc. (\u201cFzioMed\u201d or the \u201cCompany\u201d), a global leading surgical biomaterials company focused on spine\/orthopedic, peritoneal and gynecological surgery, today announced the appointment of [&hellip;]","og_url":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/","og_site_name":"Fziomed USA","article_published_time":"2023-01-04T00:04:01+00:00","author":"raincastle","twitter_card":"summary_large_image","twitter_misc":{"Written by":"raincastle","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/#article","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/"},"author":{"name":"raincastle","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c"},"headline":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO","datePublished":"2023-01-04T00:04:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/"},"wordCount":576,"commentCount":0,"articleSection":["News Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/","url":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/","name":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO - Fziomed USA","isPartOf":{"@id":"https:\/\/www.fziomed.com\/usa\/#website"},"datePublished":"2023-01-04T00:04:01+00:00","author":{"@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c"},"breadcrumb":{"@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.fziomed.com\/usa\/fziomed-appoints-industry-veteran-paul-mraz-as-new-president-and-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fziomed.com\/usa\/home\/"},{"@type":"ListItem","position":2,"name":"FzioMed Appoints Industry Veteran Paul Mraz as New President and CEO"}]},{"@type":"WebSite","@id":"https:\/\/www.fziomed.com\/usa\/#website","url":"https:\/\/www.fziomed.com\/usa\/","name":"Fziomed USA","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fziomed.com\/usa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.fziomed.com\/usa\/#\/schema\/person\/d08a21ddbf0edf65250f5c26f5e2f05c","name":"raincastle","sameAs":["https:\/\/www.fziomed.com"],"url":"https:\/\/www.fziomed.com\/usa\/author\/raincastle\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/2461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/comments?post=2461"}],"version-history":[{"count":0,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/posts\/2461\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/media?parent=2461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/categories?post=2461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fziomed.com\/usa\/wp-json\/wp\/v2\/tags?post=2461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}